Clinical trial
Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not…
NCT00181766 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181766 |
|---|---|
| Title | Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS) |
| Official title | A Pilot Study of Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | ADHD NOS |
| Intervention type | Drug |
| Interventions | Strattera (atomoxetine) |
| Enrollment | 45 |
| Start date | Dec 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 21, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: